Schedule a Consultation | Toll Free: 1-800-678-1307
Trial lawyers specializing in personal injury and civil litigation

Pfizer settles off-label marketing claims involving Bextra reported yesterday that Pfizer, Inc. took a $2.3 billion dollar charge in order to pay a record settlement with the federal government over claims that it had improperly marketed the pain killer, Bextra.  The drug was recalled in 2005 over a rare skin condition.  In the interim, Pfizer apparently admitted to the government that it had reaped billions in profit by marketing the drug to doctors for use in a manner not approved by the FDA.   It is likely that Pfizer still showed a significant profit for its sales of Bextra, despite the fact that it was sanctioned heavily for what turned out to be an unsafe product.

Thompson O’Neil, P.C.
309 East Front Street
Traverse City, Michigan 49684
Toll Free: 1-800-678-1307
Fax: 231-929-7262